The core laboratory tests used to diagnose and monitor treatment efficacy in VWD involve the assessment of FVIII activity (%, U/dL or U/mL) and VWF protein level (Ag) and activity. This evidence concerns the gene F8 and von Willebrand disease (hereditary or acquired).